Reactions Weekly

, Volume 1658, Issue 1, pp 409–409 | Cite as


Rash: case report
Case report

A retrospective study described a patient [age and sex not stated] who developed rash [time to reaction onset not stated] following the administration of rufinamide [route and dosage not stated] for epilepsy. Rufinamide was discontinued [outcome not stated].

Author comment: "Only one patient discontinued before 1 month, due to a rash."


  1. Tan HJ, et al. Effectiveness and Tolerability of Rufinamide in Children and Young People: A Survey of Experience from the United Kingdom. Journal of Pediatric Epilepsy 6: 103-110, No. 2, Jun 2017. Available from: URL: - United KingdomCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations